Macrogenics (MGNX) Cash from Investing Activities Growth (3y) (2015 - 2026)
Macrogenics (MGNX) Cash from Investing Activities Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Macrogenics |
260.14 Mn |
193.63 Mn |
- |
17.28% |
| Date | Value |
|---|
| Mar 31, 2026 |
17.28% |
| Dec 31, 2025 |
-125.07% |
| Sep 30, 2025 |
-31.68% |
| Jun 30, 2025 |
-53.74% |
| Mar 31, 2025 |
36.37% |
| Dec 31, 2024 |
71.67% |
| Sep 30, 2024 |
149.88% |
| Jun 30, 2024 |
50.85% |
| Mar 31, 2024 |
39.66% |
| Dec 31, 2023 |
64.05% |
| Sep 30, 2023 |
8.16% |
| Jun 30, 2023 |
-68.30% |
| Mar 31, 2023 |
38.55% |
| Dec 31, 2022 |
-40.25% |
| Sep 30, 2022 |
136.87% |
| Jun 30, 2022 |
62.32% |
| Mar 31, 2022 |
36.00% |
| Dec 31, 2021 |
-32.01% |
| Sep 30, 2021 |
-658.38% |
| Jun 30, 2021 |
55.62% |
